We are going to take a close look at [market_watch ticker=MBRX item=name value=”Moleculin Biotech Inc.”] ([market_watch ticker=MBRX item=ticker value=”NASDAQ: MBRX”]) today to get a better sense...
Medical Marijuana Inc (OTCMKTS:MJNA) has announced that its major investment company, Axim Bio-technologies Inc (OTCMKTS:AXIM), is making progress with its phase-2 clinical trials, for the treatment...
Cannabis Science Inc (OTCMKTS:CBIS) has announced that it has completed the development of its cannabinoid-based pain patches, which is now in the packaging phase. The company...
Marijuana Company Of America Inc (OTCMKTS:MCOA) recently signed a letter of intent, with Bougainville Ventures Inc, for housing tenant growers of legal marijuana, in the state...
Pazoo Inc (OTCMKTS:PZOO) recorded a trade volume of 52.84 million, during the February 15 trading session, but failed to record a change in its share value....
Cannabis Science Inc (OTCMKTS:CBIS) has announced that it has successfully negotiated an investment opportunity, with Crown Baus Capital Corp (OTCMKTS:CBCA), with regard to its ongoing development...
As the race for patent filing in marijuana space becomes more volatile, Axim Biotechnologies Inc (OTCMKTS:AXIM), recently announced securing new patent grant for its cannabinoids based chewing...
Axim Biotechnologies Inc (OTCMKTS:AXIM) starts off 2017 with its efforts to develop a wider Cannabinoid Therapeutics portfolio, but with much lower cost. In a recent publication...
CV Sciences Inc (OTCMKTS:CVSI) is the life science company, which is involved primarily in development and commercialization of therapies that use synthetic Cannabidiol (Hemp). The company...
INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) recently released its year end review for 2016. Was the year that has gone by, good or bad for the company?...